Skip to main content
2026 CRT Conference Main banner

CRT 2026

Endovascular

Session:: Access Closure | Supported through an Educational Grant by Terumo Medical

Panel Discussion | Vascular Access and Closure-Related Issues

Saturday, March 7, 2026
12:05 PM - 12:25 PM EST
Location: Jefferson

    Moderator(s)

  • Ramesh Daggubati, MD, FACC, FSCAI

    Vice Chair of the Department of Cardiology & Chief of Interventional Cardiology
    JW Ruby Memorial Hospital, West Virginia University
    Morgantown, West Virginia, United States

    Disclosure(s): Medtronic, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Aravinda Nanjundappa, MD, FSCAI

    Director of Peripheral Vascular Interventions, Cardiovascular Division
    Cleveland Clinic , Main Campus
    Pepper pike, Ohio, United States

    Disclosure(s): No financial relationships to disclose

  • Shawn N. Sarin, MD

    Director, VIR
    The George Washington University Hospital
    Washington, District of Columbia, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Jeffrey E. Cohen, MD

    Attending Cardiac Surgeon
    Washington Hospital Center
    Washington, District of Columbia, United States

    Disclosure information not submitted.

  • ME

    Marvin Eng, MD

    Section Chief, Interventional Cardiology Structural Heart Medical Director
    University of Nebraska Medical Center
    Omaha, Nebraska, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Amir Kaki, MD, FACC, FSCAI

    Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
    Henry Ford St John Hospital
    Birmingham, Michigan, United States

    Disclosure information not submitted.

  • Venkatesh Ramaiah, MD, FACS

    Co Founder and Chief PULSE CARDIOVASCULAR INSTITUTE CHAIRMAN TEDCONGRESS CONSULTANT ARIZONA HEART INSTITUTE OSBORN MEDICAL CENTER
    Pulse Cardiovascular Institute
    Scottsdale, Arizona, United States

    Disclosure information not submitted.

  • Toby Rogers, MD, PhD

    Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
    Georgetown University and MedStar Washington Hospital Center
    Washington, District of Columbia, United States

    Disclosure information not submitted.

  • Peter A. Soukas, MD, FSCAI

    Director, Vascular Medicine & Interventional PV Lab
    Brown University Health Cardiovascular Institute/ Brown Medical School
    Providence, Rhode Island, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Endologix, Contego Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Grant/Research Support (Ongoing)

  • Michael C. Stoner, MD

    Chief, Division of Vascular Surgery
    University of Rochester
    Rochester, New York, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Ramesh Daggubati, MD, FACC, FSCAI: Medtronic, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose
Marvin Eng, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing)
Peter A. Soukas, MD, FSCAI: Abbott Vascular, Medtronic, Boston Scientific, Endologix, Contego Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Grant/Research Support (Ongoing)
Michael C. Stoner, MD: No financial relationships to disclose